Oligodendroglioma: CD44 as a possible prognostic opportunity

Clinical Neuropathology

Volumn 22, Issue 4, 2003, Pages 169-175

  Buccoliero, A M ^a   Caldarella, A ^a   Arganini, L ^a   Mennonna, P ^a   Ammanati, F ^a   Taddei, A ^a   Taddei, G L ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Brain tumors; CD44; Immunohistochemistry; Oligodendroglioma; Recurrences

Indexed keywords

CELL SURFACE PROTEIN; HERMES ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL ANALYSIS;

ADULT; AGED; ANTIGENS, CD44; BRAIN NEOPLASMS; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OLIGODENDROGLIOMA; PROGNOSIS; PROTEIN ISOFORMS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0037817622     PISSN: 07225091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Aray Y, Takashima S, Becker LE 2000 CD44 expression in tuberous sclerosis. Pathobiology 68: 87-92
2. Ariza A, López D, Mate JM, Isamat M, Musulén E, Pujol M, Ley A, Navas-Palacios JJ 1995 Role of CD44 in the invasiveness of glioblastoma multiforme and the non-invasiveness of meningioma: an immunohistochemistry study. Hum Pathol 26: 1144-1147
3. Baltuch GH, de Tribolet N, Van Meir EG 1995 Expression of the CD44 adhesion molecule in tumours of the central and peripheral nervous system. J Neurooncol 26: 191-198
4. Birner P, Gatterbauer B, Oberthuber G, Schindl M, Rössler K, Prodinger A, Budka H, Hainfellner JA 2001 Expression of hypoxia-inducible factor-1α in oligodendrogliomas. Its impact on prognosis and neoangiogenesis. Cancer 92: 165-171
5. Breyer R, Hussein S, Radu DL, Putz KM, Gunia S, Hecker H, Samii M, Walter GF, Stan AC 2000 Disruption of intracerebral progression of C6 rat glioblastoma by in vivo treatment with anti-CD44 monoclonal antibody. J Neurosurg 92: 140-149
6. Chinot O 2001 Chemotherapy for the treatment of oligodendroglial tumors. Semin Oncol 28: 13-18
7. Daumas-Duport C, Tucker ML, Kolles H, Cervera P, Beuvon F, Varlet P, Udo N, Koziak M, Chodkiewicz JP 1997 Oligodendrogliomas. Part II: A new grading system based on morphological and imaging criteria. J Neurooncol 34: 61-78
8. Delpech B, Maigonnat C, Girard N, Chauzy C, Maunoury R, Olivier A, Tayot J, Creissard P 1993 Hyaluronan and hyaluronectin in the extracellular matrix of human brain tumour stroma. Eur J Cancer 29A: 1012-1017
9. Frank S, Rihs HO, Stocker W, Muller J, Dumont B, Baur X, Schackert HK, Schackert G 1996 Combined detection of CD44 isoforms by exon-specific RT-PCR and immunohistochemistry in primary human brain tumors and brain metastases. Biochem Biophys Res Commun 24: 794-801
10. Gunia S, Hussein S, Radu DL, Putz KM, Breyer R, Hecker H, Samii M, Walter GF, Stan AC 1999 CD44s-targeted treatment with monoclonal antibody blocks intracerebral invasion and growth of 9L gliosarcoma. Clin Exp Metastas 17: 221-230
11. Gunthert U, Hofinan M, Rudy W, Reber S, Zoller M, Haussmann I, Matzku S, Wenzwl A, Ponta H, Herrlich P 1991 A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65: 13-24
12. Hagel C, Stavrou DK 1999 CD44 expression in primary and recurrent oligodendrogliomas and in adjacent gliotic brain tssue. Neuropathol Appl Neurobiol 25: 313-318
13. Herrlich P, Pals S, Ponta H 1995 CD44 in colon cancer. Eur J Cancer 31A: 1110-1112
14. Kaaijk P, Troost D, Morsink F, Keen RM, Leenstra S, Bosch DA, Pals ST 1995 Expression of CD44 splice variants in human primary brain tumors. J Neurooncol 26: 185-190
15. Kaufmann M, Heider KH, Sinn HP, von Minckwitz G, Ponta H, Herrlich P 1995 CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 345: 615-619
16. Knudson CB, Knudson W 1993 Hyaluronan-binding protein in development, tissue homeostasis and disease. FASEB J 7: 1233-1241
17. Knudson W 1998 The role of CD44 as a cell surface hyaluronan receptor during tumor invasion of connective tissue. Front Biosci 1: D604-615
18. Kros JM, Hop WC, Godschalk JJ, Krishnadath KK 1996 Prognostic value of the proliferation-related antigen Ki-67 in oligodendrogliomas. Cancer 78: 1107-1113
19. Korshunov A, Golanov A 2001 The prognostic significance of DNA topoisomerase II-alpha (Ki-S1), p21/Cip-1, and p27/Kip-1 protein immunoexpression in oligodendrogliomas. Arch Pathol Lab Med 125: 892-898
20. Kuppner MC, van Meir E, Gauthier T, Hamou MF, de Tribolet N 1992 Differential expression of the CD44 molecule in human brain tumours. Int J Cancer 50: 572-577
21. Lees VC, Fan TP, West DC 1995 Angiogenesis in a delayed revascularization model is accelerated by angiogenic oligosaccharides of hyaluronan. Lab Invest 73: 259-266
22. Li H, Hofmann M, Hamou MF, de Tribolet N 1995a Differential CD44 expression patterns in primary brain tumours and brain metastases. Br J Cancer 72: 160-163
23. Li H, Liu J, Hofmann M, Hamou MF, de Tribolet N 1995b Differential CD44 expression patterns in primary brain tumours and brain metastases. Br J Cancer 72: 160-163
24. Mackay CR, Terpe HJ, Martson WL, Stark H, Gunthert U 1994 Expression and modulation of CD44 variant isoforms in humans. J Cell Biol 124: 71-82
25. Merzak A, Koocheckpour S, Pilkington GJ 1994 CD44 mediates human glioma cell adhesion and invasion in vitro. Cancer Res 54: 3988-3992
26. Nagasaka S, Tanabe KK, Bruner JM, Saya H, Sawaya RE, Morruson RS 1995 Alternative RNA splicing of the hyaluronic acid receptor CD44 in the normal human brain and in brain tumors. J Neurosurg 82: 858-863
27. Peterson K, Cairncross JG 1995 Oligodendrogliomas. Neurol Clin 13: 861-873
28. Rahmanian M, Pertoft H, Kanda S, Christofferson R, Claesson-Welsh L, Heldin P 1997 Hyaluronan oligosaccharides induces tube formation of a brain endothelial cell line in vitro. Exp Cell Res 237: 223-230
29. Reifenberger G, Kros JM, Burger PC, Louis DN, Collins VP 2000 Oligodendroglial tumors and mixed gliomas In: Kleihues P, Cavenee WK (eds) World Health Organization of Tumors. Pathology and Genetics of Tumors of the Nervous System. IARC Press, Lyon, pp 55-69
30. Resnick DK, Resnick NM, Welch WC, Cooper DL 1999 Differential expression of CD44 variants in tumors affecting the central nervous system. Mol Diagn 4: 219-232
31. Rodriguez C, Monges G, Rouanet P, Dutrillaux B, Lefrancois D, Theillet C 1995 CD44 expression patterns in breast and colon tumors: a PCR-based study of splice variants. Int J Cancer 64: 347-354
32. Sattar A, Rooney P, Kumar S, Pye D, West DC, Scott I, Ledger P 1994 Application of angiogenic oligosaccharides of hyaluronan increases blood vessel numbers in rat skin. J Invest Dermatol 103: 576-579
33. Savani RC, Cao G, Pooler PM, Zaman A, Zhou Z, DeLisser HM 2001 Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis. J Biol Chem 39: 36770-36778
34. Schiffer D, Dutto A, Cavalla P, Bosone I, Chio A, Villani R, Bellotti C 1997 Prognostic factor in oligodendroglioma. Can J Neurol Sci 24: 313-319
35. Smith MT, Ludwig CL, Godfrey AD, Armbrustmacher VW 1983 Grading of oligodendrogliomas. Cancer 52: 2107-2114
36. Taddei GL, Arganini L, Raspollini MR, Mennonna P, Vannelli B, Nesi G, Buccoliero AM 2001 Oligodendroglioma: HMB-45 positivity using catalyzed signal amplification method. Appl Immunohistochem Mol Morphol 9: 35-41
37. Takeuchi K, Yamaguchi A, Urano T, Goi T, Nakagawara G, Shiku H 1995 Expression of CD44 variant exons 8-10 in colorectal cancer and its relationship to metastasis. Jpn J Cancer Res 86: 292-297
38. Vaquero J, Zurita M, Morales C, Coca S 2001 Prognostic significance of the endothelial surface in low-grade resected oligodendrogliomas. Br J Neurosurg 15: 247-250
39. Varga Z, Vajtai L Aguzzi A 1996 The standard isoform of CD44 is preferentially expressed in atypical papillomas and carcinomas of the choroid plexus. Pathol Res Pract 192: 1225-1231
40. Varlet P, Guillamo JS, Nataf F, Korziak M, Beuvon F, Fallet C, Daumas-Duport C 2000 Vascular endothelial growth factor expression in oligodendrogliomas: a correlative study with Sainte-Anne malignancy grade, growth fraction and patient survival. Neuropathol. Appl Neurobiol 26: 379-389
41. Vogel H, Butcher EC, Picker LJ 1992 H-CAM expression in the human nervous system: evidence for a role in diverse glial interactions. 21: 363-373
42. West DC, Hampson IN, Arnold F, Kumar S 1985 Angiogenesis induced by degradation products of hyaluronic acid. Science 228: 1324-1326
43. Wimmel A, Kogan E, Ramaswamy A, Schuermann M 2001 Variant expression of CD44 in preneoplasic lesions of the lung. Cancer 92: 1231-1236
44. Ylagan LR, Quinn B 1997 CD44 expression in astrocytic tumors. Mod Pathol 10: 1239-1246